Cargando…
Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study
BACKGROUND: Previous studies assessed the prognostic effect of aspirin, statins, and metformin in breast cancer (BC) patients, with inconclusive results. METHODS: We performed a nationwide population-based cohort study to evaluate if post-diagnostic use of low-dose aspirin, statins, and metformin wa...
Autores principales: | Löfling, L. Lukas, Støer, Nathalie C., Andreassen, Bettina Kulle, Ursin, Giske, Botteri, Edoardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10466817/ https://www.ncbi.nlm.nih.gov/pubmed/37649039 http://dx.doi.org/10.1186/s13058-023-01697-2 |
Ejemplares similares
-
Low-dose aspirin and risk of breast cancer: a Norwegian population-based cohort study of one million women
por: Løfling, Lukas, et al.
Publicado: (2023) -
β-blockers and breast cancer survival by molecular subtypes: a population-based cohort study and meta-analysis
por: Løfling, L. Lukas, et al.
Publicado: (2022) -
Identification of potential carcinogenic and chemopreventive effects of prescription drugs: a protocol for a Norwegian registry-based study
por: Andreassen, Bettina Kulle, et al.
Publicado: (2019) -
Metformin use and lung cancer survival: a population-based study in Norway
por: Brancher, Suzan, et al.
Publicado: (2020) -
Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway
por: Botteri, Edoardo, et al.
Publicado: (2017)